PHATHOM PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
PHATHOM PHARMACEUTICALS, INC. (PHAT) reported Basic Shares Outstanding (Weighted Average) of 83.75 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-30
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 83.75M shares, a 15.57% increase year-over-year.
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 82.05M shares, a 14.01% increase year-over-year.
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 73.83M shares, a 3.87% increase year-over-year.
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 73.40M shares, a 13.57% increase year-over-year.
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 72.92M shares, a 15.42% increase from fiscal 2024.
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 63.18M shares, a 23.18% increase from fiscal 2023.
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 51.29M shares, a 31.11% increase from fiscal 2022.
- PHATHOM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 39.12M shares, a 5.72% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 83.75M shares 10-Q · filed 2026-07-30 | 82.90M shares 10-Q · filed 2026-07-30 | 79.88M shares derived: average of 3 quarters · filed 2026-07-30 | 78.26M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | 82.05M shares 10-Q · filed 2026-04-30 | 77.94M shares derived: average of 2 quarters · filed 2026-04-30 | 76.42M shares derived: average of 3 quarters · filed 2026-04-30 | 75.44M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | 73.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 73.61M shares derived: average of 2 quarters · filed 2026-02-26 | 73.23M shares derived: average of 3 quarters · filed 2026-07-30 | 72.92M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 73.40M shares 10-Q · filed 2025-10-30 | 72.93M shares derived: average of 2 quarters · filed 2026-07-30 | 72.62M shares 10-Q · filed 2025-10-30 | 72.23M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | 72.47M shares 10-Q · filed 2026-07-30 | 72.22M shares 10-Q · filed 2026-07-30 | 71.84M shares derived: average of 3 quarters · filed 2026-07-30 | 70.03M shares derived: average of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | 71.97M shares 10-Q · filed 2026-04-30 | 71.52M shares derived: average of 2 quarters · filed 2026-04-30 | 69.22M shares derived: average of 3 quarters · filed 2026-04-30 | 66.56M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 71.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 67.85M shares derived: average of 2 quarters · filed 2026-02-26 | 64.75M shares derived: average of 3 quarters · filed 2026-02-26 | 63.18M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 64.63M shares 10-Q · filed 2025-10-30 | 61.59M shares derived: average of 2 quarters · filed 2025-10-30 | 60.54M shares 10-Q · filed 2025-10-30 | 59.73M shares derived: average of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | 58.56M shares 10-Q · filed 2025-08-07 | 58.46M shares 10-Q · filed 2025-08-07 | 58.10M shares derived: average of 3 quarters · filed 2025-08-07 | 57.77M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 58.37M shares 10-Q · filed 2025-05-01 | 57.87M shares derived: average of 2 quarters · filed 2025-05-01 | 57.50M shares derived: average of 3 quarters · filed 2025-05-01 | 55.25M shares derived: average of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | 57.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 57.07M shares derived: average of 2 quarters · filed 2025-03-06 | 54.21M shares derived: average of 3 quarters · filed 2025-03-06 | 51.29M shares 10-K · filed 2025-03-06 |
| 2023-09-30 | 56.78M shares 10-Q · filed 2024-11-07 | 52.64M shares derived: average of 2 quarters · filed 2024-11-07 | 49.27M shares 10-Q · filed 2024-11-07 | 47.24M shares derived: average of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 48.50M shares 10-Q · filed 2024-08-08 | 45.44M shares 10-Q · filed 2024-08-08 | 44.06M shares derived: average of 3 quarters · filed 2024-08-08 | 42.75M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 42.35M shares 10-Q/A · filed 2024-06-14 | 41.84M shares derived: average of 2 quarters · filed 2024-06-14 | 40.84M shares derived: average of 3 quarters · filed 2024-06-14 | 40.20M shares derived: average of 4 quarters · filed 2024-06-14 |
| 2022-12-31 | 41.33M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-14 | 40.08M shares derived: average of 2 quarters · filed 2024-06-14 | 39.48M shares derived: average of 3 quarters · filed 2024-06-14 | 39.12M shares 10-K/A · filed 2024-06-14 |
| 2022-09-30 | 38.82M shares 10-Q · filed 2023-11-09 | 38.55M shares derived: average of 2 quarters · filed 2023-11-09 | 38.38M shares 10-Q · filed 2023-11-09 | 38.22M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 38.27M shares 10-Q · filed 2023-08-10 | 38.16M shares 10-Q · filed 2023-08-10 | 38.03M shares derived: average of 3 quarters · filed 2023-08-10 | 37.84M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 38.04M shares 10-Q · filed 2023-05-10 | 37.90M shares derived: average of 2 quarters · filed 2023-05-10 | 37.70M shares derived: average of 3 quarters · filed 2023-05-10 | 37.43M shares derived: average of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | 37.77M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-02-28 | 37.53M shares derived: average of 2 quarters · filed 2023-02-28 | 37.23M shares derived: average of 3 quarters · filed 2023-02-28 | 37.00M shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 37.30M shares 10-Q/A · filed 2022-11-09 | 36.97M shares derived: average of 2 quarters · filed 2022-11-09 | 36.75M shares 10-Q/A · filed 2022-11-09 | |
| 2021-06-30 | 36.64M shares 10-Q · filed 2022-08-02 | 36.47M shares 10-Q · filed 2022-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |